Glenmark gets CDSCO panel nod to manufacture and market COPD drug Dr. Divya Colin9 May 2022 6:52 PM ISTNew Delhi: Based on the justification provided by the pharmaceutical major Glenmark pharmaceuticals, the Subject Expert Committee (SEC) of the Central...
CDSCO allows import of drugs with residual shelf life less than 60 percent till October 31, 2021 Susmita Roy8 May 2022 12:00 PM ISTNew Delhi: With an aim to ensure drug availability in sufficient quantity in the domestic market, the apex drug regulator, Central Drugs Standard...
Paxlovid not be included in national treatment guidelines for COVID-19, says ICMR MD Bureau7 May 2022 1:01 PM ISTExperts from the Indian Council of Medical Research (ICMR) have not found a compelling reason to include the drug in the national treatment guidelines...
CDSCO panel directs GSK to generate safety, immunogenicity data on Indian population for INFANRIX-IPV Dr. Divya Colin6 May 2022 7:06 PM ISTNew Delhi: Rejecting pharmaceuticals major GSK's proposal to import INFANRIX-IPV in the country without conducting a local clinical trial, the Subject...
CDSCO panel directs SII to submit safety and immunogenicity data for TB vaccine Susmita Roy5 May 2022 7:10 PM ISTNew Delhi: Rejecting the vaccine major Serum Inst. of India's proposal for emergency use authorization of rBCG vaccine for prevention of Tuberculosis...
Eris Lifesciences to acquire Oaknet Healthcare for Rs 650 crore Ruchika Sharma4 May 2022 11:19 AM ISTMr Krishnakumar V, Executive Director & Chief Operating Officer of Eris Lifesciences Ltd., added, "The acquisition of Oaknet brings marquee brands...
Huntington's disease drug: Teva Pharma settles patent dispute with Lupin, continues to litigate against Aurobindo Ruchika Sharma3 May 2022 4:05 PM ISTUnder the terms of the settlement agreement, Lupin will have a license to sell its generic product beginning April 2033, or earlier under certain...
Pfizer's COVID drug Paxlovid fails to show benefit as preventive therapy Ruchika Sharma2 May 2022 10:58 AM ISTThe results were not statistically significant and thus possibly due to chance.
Bristol Myers Squibb gets USFDA nod for obstructive hypertrophic cardiomyopathy drug Camzyos Ruchika Sharma1 May 2022 10:30 AM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (USFDA) has approved Camzyos (mavacamten, 2.5 mg, 5...
Tamil Nadu: All Pharmacists Association stages protest, demanding 1200 vacancies to be filled MD Bureau30 April 2022 3:49 PM ISTTamil Nadu: The members of All Pharmacists Association of Tamil Nadu on Thursday staged a demonstration in the form of protest, demanding the...
Drug safety alert: IPC flags adverse reactions linked to Cefuroxime Susmita Roy29 April 2022 8:52 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of April, has revealed that a...
Drug alert: CDSCO flags 48 drugs as not of standard quality Susmita Roy28 April 2022 6:54 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) flagged 48 medicine...
